<p>以 57.6 倍的市盈率（&#34;P/E&#34;）来看，<strong>时代天使</strong>（HKG:6699）目前可能发出非常悲观的信号，因为香港几乎一半的公司市盈率低于 12 倍，甚至低于 7 倍的市盈率也并不罕见。不过，我们需要更深入地探讨，以确定这种高市盈率是否有合理的基础。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>时代天使最近的表现确实不错，其盈利增长超过了大多数其他公司。市盈率之所以可能偏高，是因为投资者认为这种强劲的盈利表现将会持续。如果不是，那么现有股东可能会对股价的可持续性感到有些紧张。</p>
<p>查看我们对时代天使的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/714667957-pe-multiple-vs-industry-1-dark-2/1764110185373?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/714667957-pe-multiple-vs-industry-1-dark-2/1764110185373"/></p>
<p>SEHK:6699 市盈率与行业比较 2025 年 11 月 25 日</p>
<p>想知道分析师如何看待时代天使的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
<h2>时代天使的增长趋势如何？</h2>
<p>为了证明其市盈率的合理性，时代天使需要实现远超市场的卓越增长。</p>
<p>回顾过去一年，公司实现了 276% 的非凡增长。尽管最近增长强劲，但由于其三年每股收益整体下降了 42%，仍然难以追赶。因此，不幸的是，我们必须承认该公司在这段时间内并没有很好地实现盈利增长。</p>
<p>展望未来，覆盖该公司的 11 位分析师的估计显示，未来三年每年盈利应增长 10%。与此同时，市场其他部分的年增长率预计为 14%，这显然更具吸引力。</p>
<p>根据这些信息，我们发现时代天使的市盈率高于市场，这令人担忧。似乎大多数投资者希望公司的商业前景会出现转机，但分析师群体对此并不太有信心。如果市盈率降至与增长前景更为一致的水平，这些股东很可能会面临未来的失望。</p>
<h2>我们可以从时代天使的市盈率中学到什么？</h2>
<p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
<p>我们已经确定，时代天使目前的市盈率远高于预期，因为其预测增长低于更广泛的市场。现在，我们对高市盈率越来越感到不安，因为预测的未来盈利不太可能长期支持如此积极的情绪。这使得股东的投资面临重大风险，而潜在投资者则可能面临支付过高溢价的危险。</p>
<p>公司的资产负债表中可能存在许多潜在风险。查看我们对时代天使的 <strong>免费</strong> 资产负债表分析，其中包含对一些关键因素的六项简单检查。</p>
<p>当然，<strong>你也可能找到比时代天使更好的股票</strong>。因此，你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>

时代天使

<p>时代天使科技有限公司 (HKG:6699) 的市盈率高达 57.6 倍，显示出潜在的看跌情绪。尽管近期盈利增长，但其长期每股收益下降了 42%。未来的增长预计为每年 10%，低于市场的 14%。这引发了对其股价可持续性的担忧，如果市盈率下降以符合增长预期，可能会导致股东失望</p>

<p>With a price-to-earnings (or &#34;P/E&#34;) ratio of 57.6x <strong>Angelalign Technology Inc.</strong> (HKG:6699) may be sending very bearish signals at the moment, given that almost half of all companies in Hong Kong have P/E ratios under 12x and even P/E's lower than 7x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.</p>
<div class="lb-trans"><p>以 57.6 倍的市盈率（&#34;P/E&#34;）来看，<strong>时代天使</strong>（HKG:6699）目前可能发出非常悲观的信号，因为香港几乎一半的公司市盈率低于 12 倍，甚至低于 7 倍的市盈率也并不罕见。不过，我们需要更深入地探讨，以确定这种高市盈率是否有合理的基础。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>Angelalign Technology certainly has been doing a good job lately as it's been growing earnings more than most other companies. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>时代天使最近的表现确实不错，其盈利增长超过了大多数其他公司。市盈率之所以可能偏高，是因为投资者认为这种强劲的盈利表现将会持续。如果不是，那么现有股东可能会对股价的可持续性感到有些紧张。</p>
</div><p>View our latest analysis for Angelalign Technology</p>
<div class="lb-trans"><p>查看我们对时代天使的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/714667957-pe-multiple-vs-industry-1-dark-2/1764110185373" alt="" original-src="https://images.simplywall.st/asset/chart/714667957-pe-multiple-vs-industry-1-dark-2/1764110185373"/></p>
<p>SEHK:6699 Price to Earnings Ratio vs Industry November 25th 2025</p>
<div class="lb-trans"><p>SEHK:6699 市盈率与行业比较 2025 年 11 月 25 日</p>
</div><p>Keen to find out how analysts think Angelalign Technology's future stacks up against the industry? In that case, our <strong>free</strong> report is a great place to start.</p>
<div class="lb-trans"><p>想知道分析师如何看待时代天使的未来与行业的对比吗？在这种情况下，我们的 <strong>免费</strong> 报告是一个很好的起点。</p>
</div><h2>How Is Angelalign Technology's Growth Trending?</h2>
<div class="lb-trans"><h2>时代天使的增长趋势如何？</h2>
</div><p>In order to justify its P/E ratio, Angelalign Technology would need to produce outstanding growth well in excess of the market.</p>
<div class="lb-trans"><p>为了证明其市盈率的合理性，时代天使需要实现远超市场的卓越增长。</p>
</div><p>Retrospectively, the last year delivered an exceptional 276% gain to the company's bottom line. Despite this strong recent growth, it's still struggling to catch up as its three-year EPS frustratingly shrank by 42% overall. So unfortunately, we have to acknowledge that the company has not done a great job of growing earnings over that time.</p>
<div class="lb-trans"><p>回顾过去一年，公司实现了 276% 的非凡增长。尽管最近增长强劲，但由于其三年每股收益整体下降了 42%，仍然难以追赶。因此，不幸的是，我们必须承认该公司在这段时间内并没有很好地实现盈利增长。</p>
</div><p>Shifting to the future, estimates from the eleven analysts covering the company suggest earnings should grow by 10% per annum over the next three years. Meanwhile, the rest of the market is forecast to expand by 14% per annum, which is noticeably more attractive.</p>
<div class="lb-trans"><p>展望未来，覆盖该公司的 11 位分析师的估计显示，未来三年每年盈利应增长 10%。与此同时，市场其他部分的年增长率预计为 14%，这显然更具吸引力。</p>
</div><p>With this information, we find it concerning that Angelalign Technology is trading at a P/E higher than the market. It seems most investors are hoping for a turnaround in the company's business prospects, but the analyst cohort is not so confident this will happen. There's a good chance these shareholders are setting themselves up for future disappointment if the P/E falls to levels more in line with the growth outlook.</p>
<div class="lb-trans"><p>根据这些信息，我们发现时代天使的市盈率高于市场，这令人担忧。似乎大多数投资者希望公司的商业前景会出现转机，但分析师群体对此并不太有信心。如果市盈率降至与增长前景更为一致的水平，这些股东很可能会面临未来的失望。</p>
</div><h2>What We Can Learn From Angelalign Technology's P/E?</h2>
<div class="lb-trans"><h2>我们可以从时代天使的市盈率中学到什么？</h2>
</div><p>Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>一般来说，我们倾向于将市盈率的使用限制在评估市场对公司整体健康状况的看法上。</p>
</div><p>We've established that Angelalign Technology currently trades on a much higher than expected P/E since its forecast growth is lower than the wider market. Right now we are increasingly uncomfortable with the high P/E as the predicted future earnings aren't likely to support such positive sentiment for long. This places shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.</p>
<div class="lb-trans"><p>我们已经确定，时代天使目前的市盈率远高于预期，因为其预测增长低于更广泛的市场。现在，我们对高市盈率越来越感到不安，因为预测的未来盈利不太可能长期支持如此积极的情绪。这使得股东的投资面临重大风险，而潜在投资者则可能面临支付过高溢价的危险。</p>
</div><p>A lot of potential risks can sit within a company's balance sheet. Take a look at our <strong>free</strong> balance sheet analysis for Angelalign Technology with six simple checks on some of these key factors.</p>
<div class="lb-trans"><p>公司的资产负债表中可能存在许多潜在风险。查看我们对时代天使的 <strong>免费</strong> 资产负债表分析，其中包含对一些关键因素的六项简单检查。</p>
</div><p>Of course, <strong>you might also be able to find a better stock than Angelalign Technology</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>当然，<strong>你也可能找到比时代天使更好的股票</strong>。因此，你可能希望查看这份 <strong>免费</strong> 的其他公司集合，这些公司具有合理的市盈率并且盈利增长强劲。</p>
</div>

Unpleasant Surprises Could Be In Store For Angelalign Technology Inc.'s (HKG:6699) Shares

- Angelalign Technology 的市盈率为 57.6 倍，远高于香港大多数公司。  
- 尽管最近盈利增长显著，但三年内每股收益下降 42%。  
- 分析师预计未来三年年增长率为 10%，低于市场 14% 的预期。  

时代天使科技有限公司（HKG:6699）的股票可能会面临不愉快的意外